![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 49, 35139-35146, December 3, 1999
2,8/2,9-Polysialyltransferase from
Escherichia coli K92
,
,From the Department of Chemistry and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California 92037
| |
ABSTRACT |
|---|
|
|
|---|
The capsular polysaccharide of Escherichia
coli K92 contains alternating -8-NeuAc The 9-carbon
5-amino-3,5-dideoxy-D-glycero-D-galactononulosonic
acids or sialic acids, comprise a family of neuraminic acid derivatives
which are widely spread in nature, ranging from bacterial to human
origin. This sugar moiety linked to carbohydrate chains of glycolipids
and glycoproteins plays a key role in many important biological events
mediated by carbohydrate-protein interactions (1). Sialic acids are
also found in linear homopolymers (polysialic acid) of
N-acetylneuraminic acid
(NeuAc)1 and
N-glycolylneuraminic acid (Neu5Gc) joined by The sialyltransferases that catalyze the addition of sialic acid to
form such diverse carbohydrate recognition molecules fall into at least
two families. While 13 clones have been obtained from mammalian systems
(12), only 4 have been cloned from bacterial systems to date (13-16).
Recent cloning of both mammalian and bacterial sialyltransferases
showed that these two gene families evolved differently. The
polysialyltransferase encoded by neuS in E. coli uses CMP-sialic acid as a donor and catalyzes a sequential addition of
sialic acid to the nonreducing end of an acceptor (3, 17, 18). In a
detailed study using the pathogenic strain of E. coli K1,
the gene coding for CMP-Neu5Ac:poly- Cloning of K92 neuS Gene--
The genomic DNA isolated from
E. coli strain K92 (ATCC 35860) using a DNA extraction kit
(Qiagen Co., Valencia, CA) was used for the amplification of the
neuS gene by PCR. This was performed in a 100-µl reaction
mixture containing 100 ng of genomic DNA as template, 300 nmol of
primers, 200 mM dNTPs, 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 2 mM MgCl2,
0.01% gelatin, 0.1% Triton X-100, and a mixture of both
Taq DNA polymerase and pfu DNA polymerase (1 unit
of each). Two primers, the forward primer with internal BamHI (underlined) site
(5'-ATATTGGATCC)ATATTTGATGCTAGTTTA-3'; nucleotides 3-20)
and a reverse primer with EcoRI site,
(5'-GGCGCGAATTCTTACTCCCCCAAGAAAA-3'; nucleotides
1230-1214) designed based on the previously published sequence (14)
were used for PCR using the following conditions: 94 °C, 1 min;
50 °C, 1 min; and 72 °C, 2 min for 35 cycles. Agarose gel
analysis of the product showed the presence of one major band with the
expected size of about 1.2 kilobases. The fragment obtained was
purified by agarose gel electrophoresis, digested with BamHI and EcoRI, and subcloned into a similarly digested pRSET
vector (Invitrogen Co., San Diego, CA) following standard molecular
biological techniques (21). The ligation mixture was then used for
transformation of competent cells of the BL21(DE3) strain of E. coli (Novagen, Madison, WI). The clone containing the expression
vector was confirmed by sequencing of both strands using an automated
DNA sequencer (ABI 377) at the TSRI Core facility.
Expression of the K92 neuS Gene--
Since the DH5
The transformed BL21(DE3) cells containing the neuS gene
from the K92 strain of E. coli were grown exponentially in
LB medium (with 1 mM MgCl2) containing 100 µg
of carbicillin/ml at 37 °C until A600 ~ 0.3 was reached. Expression of the neuS gene was achieved at
37 °C by induction with IPTG as described in the expression kit
(Invitrogen, Carlsbad, CA). The cells were harvested after 5 h of incubation.
Western Blot--
This analysis was done by following a standard
technique (22). The protein samples were boiled for 8-10 min in 1×
Laemmli gel sample buffer either in the absence or presence of 10%
Sialyltransferase Assay--
The assay was carried out
essentially as described by Vimr and co-workers (23) with the following
modifications: after harvesting, the cells were washed three times with
25 mM Tris-HCl (pH 8.0) and then resuspended in 25 mM Tris-HCl (pH 8.0) containing 5 mM MgCl2, 5 mM dithiothreitol (DTT), and 1 µl/ml
protease inhibitor mixture (Sigma). Cells were lysed three times by
using a French Press (Aminco; 1,500 p.s.i.). The cell debris was
removed by centrifugation twice at 15,000 rpm and the supernatant was
collected (termed the 15 K Sup). This supernatant was then centrifuged
again at 100,000 × g (~40,000 rpm) using a Beckman
ultracentrifuge (Model L5-50). Both the supernatant (termed the 40 K
Sup) and the pellet were saved. The pellet was resuspended in a buffer
containing 25 mM Tris-HCl, 5 mM
MgCl2, 5 mM DTT, and 0.1% Triton CF-54. The supernatants and the pellet were stored on ice, and used for assay within 2 h.
Without the addition of acceptor, the endogenous enzyme activity was
determined. The exogenous activity was then detected by addition of
sialic acid as acceptor and CMP-[14C]NeuAc as donor in a
reaction buffer containing 25 mM Tris-HCl (pH 8.0), 5 mM MgCl2, 5 mM DTT, and 0.5%
Triton CF-54. Other substrates were also used, including colominic
acid. Both the endogenous and exogenous enzyme activity assays measure
the transfer of 14C-labeled NeuAc to the acceptor.
Unreacted radiolabeled substrates were separated by DEAE-cellulose TLC
(1-propanol, 14 M NH4OH/H2O, 6:1:3)
or by Sephadex G-25 column chromatography. Radioactivity remaining at
the origin and/or at the top of the TLC plate or the product obtained
at the void volume of Sephadex G-25 column, was quantitated by liquid
scintillation spectrometry. For analysis using Sephadex G-25 column
chromatography, a column (1 × 3.5 cm) of Sephadex G-25 (Amersham
Pharmacia Biotech) in water was prepared. The radiolabeled cell-free
reaction mixture (60 µl) was loaded and washed with 1.5 ml of water,
which was collected and counted. In some experiments, the activity was
determined by separating the unused CMP-[14C]NeuAc by
Dowex 1X8 (phosphate form) column chromatography (24). The initial
rates were estimated graphically, and activity was expressed as
picomoles of sialic acid transferred per hour.
Thin-layer Chromatography and Fluorography--
After the
cell-free reaction was complete, the proteins were removed by an Amicon
filter (MWCO 10 K), and the supernatant containing oligomeric reaction
products was separated by Silica Gel 60 (aluminum backed) and/or
DEAE-cellulose (plastic backed) thin-layer chromatography (TLC) using
the following solvent systems: (a) 1-propanol, 14 M
NH4OH, H2O, 6:1:3; (b) chloroform, methanol, 0.02% CaCl2, 30:55:15. Control chromatograms were
calibrated with mono- to hexasialosyl oligomers (Calbiochem, San Diego,
CA) which were detected by orcinol spray, as described by Corfield and
Schauer (25). This method resolved monomeric through octameric sialic acids. Oligomers composed of nine or more sialosyl residues were retained at the origin. Labeled chromatograms were sprayed with En3Hance (NEN Life Science Products Inc.) and fluorographed
against an intensifier screen. After fluorography, sialosyl oligomers were detected on Silica Gel 60 TLC plates by orcinol spray for alignment of radioactive signals with colorimetrically detected bands.
For analysis using DEAE-cellulose TLC, the position of the cell-free
14C-labeled reaction product(s) was marked after alignment
of radioactive signals, cut and counted.
Isolation and Purification of Polysialylated
Oligosaccharides--
Strains of E. coli transformed with
vector only or with the K92 neuS gene were used for the
extraction of polysaccharide following the method of Kasper et
al. (26) with the following modifications. For K92 polysaccharide,
the K92 strain of E. coli was grown in 2 liters of Davis'
supplemental minimal medium (ATCC media formulation number 54) at
37 °C overnight. The K1 strain of E. coli transformed with the K92 neuS gene was grown in 2 liters of Davis'
supplemental minimal medium containing 2% glycerol instead of glucose.
The cells were grown to A600 ~ 0.3 and 1 mM IPTG (final concentration) was added. After incubation
at 37 °C for 1 h, M13/T7 phages (Invitrogen; 10 plaque forming
units/cell) were added and incubated at 37 °C. After overnight
growth the organisms were removed by centrifugation (48,000 × g for 30 min at 4 °C), and the supernatant was collected and filtered through a 0.45-µm Millipore filter. Hexadecyltrimethyl ammonium bromide (Cetavlon, 0.3%; Sigma) was added to the supernatant with stirring and the precipitate formed was collected by
centrifugation. The precipitate was solubilized in 0.9 M
CaCl2 and reprecipitated with 3 volumes of chilled
( Protein Assay--
This was done using bicinconic acid (BCA)
reagent following the instructions provided by the supplier (Pierce).
Mass Spectrometry Analysis--
The electrospray ionization
(ES-MS) mass spectrometry experiments were performed on an API III
Perkin-Elmer SCIEX triple quadrupole mass spectrometer. Electrospray
samples were typically introduced to the mass analyzer at a rate of 4.0 ml/min. The positive and negative ions, generated by charged droplet
evaporation, enter the analyzer through an interface plate and a 100-mm
orifice, while the declustering potential is maintained between 50 and 200 V to control the collisional energy of the ions entering the mass
analyzer. The emitter voltage is typically maintained at 5000 V. The
m/z was determined for the major peaks.
NMR Analysis--
13C nuclear magnetic resonance
spectra were recorded at about 23 °C on a Bruker AMX-400 or DRX-600
spectrometer operating in the pulsed Fourier transform mode using broad
band proton noise decoupling. The polysaccharides were run as deuterium
oxide solutions at pH 7.0. The solvent, D2O, served as an
internal lock signal. dimethyl sulfoxide was often used as internal
reference. The 13C spectrum of polysaccharides from K1 and
K92 determined in this study were found to be identical to that
presented by Egan et al. (10). The K1 polysaccharide
NHCO (amide carbonyl) resonances from the present and
Egan's studies were taken to have the same chemical shift and all
remaining signals referenced accordingly.
Cloning of the neuS Gene from K92--
Previously, the
neuS gene from the K1 strain of E. coli was
cloned and found to have the
To characterize the K92 neuS gene product, we have cloned
this gene from the E. coli K92 strain using a PCR based
approach. The primers were designed based on the previously published
sequence (14), and used to amplify the full-length clone of the
neuS gene from the genomic DNA of the K92 strain. The
1.23-kilobase fragment obtained by PCR was subcloned in pRSET
(Invitrogen) for expression of the neuS gene product as a
fusion protein with the hexameric histidine tag fused at its N-terminal
end (Fig. 1). The clone was verified by
double-strand sequencing of the entire fragment including the
restriction sites.
A hydrophilicity plot (28, 29) revealed two potential membrane-spanning
regions in this protein of 409 amino acid residues. The first one is
located 177 residues from the N terminus. It consists of 19 hydrophobic
amino acids bordered by three upstream lysine residues. Interestingly,
this first transmembrane domain is bordered on either end by a proline
residue. Proline is known to confer conformational constraints of many
biologically important proteins, as evidenced by site-directed
mutagenesis studies (see Ref. 30, for a review, see Ref. 31). A similar
KKKP motif, found to be present in the ST6Gal I (for nomenclature, see
Ref. 12) polypeptide, is part of a proposed signal anchor sequence (32). The second transmembrane domain is located 327 residues from the
N terminus. It consists of 17 hydrophobic amino acid residues bordered
by two upstream lysine residues and a proline residue at its C
terminus. Notably, lysine and serine are predominantly present in this
domain. The presence of these two transmembrane domains suggests that
this protein is membrane-bound as further supported by the Western blot
(see below). This feature appears to be unique among the cloned
bacterial sialyltransferases, the hydrophilicity plot of which suggests
the presence of only one potential membrane-spanning region.
Expression of the K92 neuS Gene--
For expression, we used pRSET
(Invitrogen), a prokaryotic expression vector designed to obtain a
hexameric histidine tag fused at the N-terminal sequence of the desired
protein. Due to the lack of any antibody available against the K92
neuS gene product, the polysialyltransferase was expressed
as a fusion protein, and detected by the Western blot using
anti-(His)5 antibody (Qiagen Inc., Valencia, CA).
SDS-Polyacrylamide Gel Electrophoresis and Western Blot--
The
cell-free crude extract (15 K Sup and 40 K Sup) and the cell pellet,
suspended in 25 mM Tris-HCl (pH 8.0) containing 5 mM MgCl2 and 0.1% Triton CF-54, obtained by
ultracentrifugation were analyzed by SDS-PAGE. Coomassie Blue staining
showed the presence of various bands including a major band at about
47.5 kDa, the expected size for the neuS gene product. This
band was absent in the control (cells transformed with pRSET vector
only). Replica gel was used to transfer the proteins to a
nitrocellulose membrane and detected by using mouse monoclonal
anti-(His)5 antibody (Qiagen, Valencia, CA). The blot was
finally developed by using Enhanced DAB substrates following the
protocol of the supplier (Pierce) or by a chemiluminescence technique
as described earlier (30). The Western blot clearly showed the presence
of a single band at about 47.5 kDa (Fig.
2). The Sialyltransferase Assay--
The cell-free crude extract (15 K
Sup), 40 K supernatant (40 K Sup), and the pellet were used for the
assay of various acceptor substrates and CMP-[14C]NeuAc
as donor substrate. The activity could be traced in all these
fractions. After the reaction was over, the products were analyzed by
TLC or Sephadex G-25 column chromatography. Fig.
3 shows a representative analysis. Using
cold sialic acid as acceptor and CMP-[14C]NeuAc as donor,
a major spot was detected on TLC using various solvent systems.
Interestingly, this new spot behaved as non-polar material on
DEAE-cellulose TLC (Fig. 3C). It was found that sialic acid
served as a good acceptor, whereas colominic acid did not (Table
I). 9-O-Acetylsialic acid was
not well accepted, indicating that polymerization probably starts at
the C-9 position of the sialic acid acceptor. Notably, pentameric and
hexameric polysialosides with Structural Determination of the Cell-free Reaction
Product--
For structural determination, the cell-free reactions
were carried out, using the 40,000 supernatant as the enzyme source, with sialic acid and unlabeled CMP-NeuAc in a molar ratio of 1:10 to
obtain the reaction product(s) in a sufficient quantity. Since it was
known that the by-product CMP inhibits the forward reaction, alkaline
phosphatase was added to remove CMP in order to increase the yield. As
mentioned above, the product moved as a non-polar material on
DEAE-cellulose TLC, a characteristic utilized for purification of the
cell-free reaction product(s). After the reaction was complete, the
reaction mixture was passed through a column of Dowex 1X8 (phosphate
form) to remove unreacted CMP-NeuAc and sialic acid. The negative ion
mass spectral analysis (ES-MS) showed (Fig.
4) a major peak at m/z 1419 for (M-3H2O
The E. coli strain K1 which forms the homopolymer of
Interestingly, the cell-free enzyme reaction product(s) appears to be
prone to lactone formation. As shown in Fig. 3, The radiolabeled
product ran as a non-polar sialoside on DEAE-cellulose TLC and also
passed through a column of Dowex 1X8 (phosphate form). Lactone
formation appears to depend on sample preparation conditions, and seems
to be preferable at lower pH. This lactonization was also observed at
pH 8.0, presumably because the pH of the reaction mixture decreased
during the reaction. The electrospray mass analysis also suggested
lactone formation of cell-free reaction product(s). The peak for
m/z at 1401 is consistent with the loss of four
H2O to form 4 lactones (Fig. 4) and the major peak for
m/z at 1419 is consistent with the formation of 3 lactones
from the pentameric product. Additional supporting evidence for the
presence of lactones is the 13C peaks at ~97 ppm, (Fig.
8), which are also observed in the
authentic pentamer lactone prepared from the partial hydrolysis of the
K92 polysaccharide. These peaks shift to ~103.5 ppm when lactone
hydrolysis under basic conditions is performed. Based on the recent
observation of regioselective lactonization of While sialic acid is ubiquitous in eukaryotes, particularly in
mammals (12), it is not detected in prokaryotes other than some
pathogenic bacteria. These include some E. coli strains, some N. meningitidis strains and bacteria of the O serotype
including Salmonella (35-37). Although the presence of
polysialyltransferase activity in E. coli was reported
earlier by Roseman et al. (17), the nature of the gene and
its product was not clearly demonstrated until recently. The cloned
neuS gene from K1 showed that its product has similar size
but no sequence homology to any of the mammalian sialyltransferases.
Expression of the K1 neuS gene indicates that this 47-kDa
protein synthesizes polysialic acid in vitro (13). A similar
gene was cloned from the K92 strain of E. coli, the capsule
of which was shown to contain heteropolysialic acid (-8NeuAc The polysialyltransferase encoded by neuS in E. coli uses CMP-sialic acid as a donor and catalyzes sequential
sialylation at the 9-position of the nonreducing end of appropriate
acceptors. Using K1 neuS, the polymerase activity was
detected in vitro with sialyloligomers (designated colominic
acid) or with certain gangliosides, such as GD3 (13) as
substrates. However, it was shown previously that this gene product
could not initiate de novo polysialic acid synthesis (23),
indicating a requirement for an as yet undefined in vivo
primer. This primer, or polymerization initiator, does not appear to be
colominic acid, since this polymer was neither elongated efficiently
in vitro (18) nor the elongated product detected in
vivo (39). Using K92 neuS, we have found that colominic acid is not an acceptor. In fact, among the acceptors tested, only
sialic acid and certain gangliosides were found to be good acceptors.
The real substrate specificity, however, remains to be investigated
using the purified enzyme.
In conclusion, this report describes for the first time that the
neuS gene product from E. coli K92 exhibits
2- and -9-NeuAc
2-
linkages. The enzyme catalyzing this polymerizing reaction has been
cloned from the genomic DNA of E. coli K92. The
1.2-kilobase polymerase chain reaction fragment was subcloned in pRSET
vector and the protein was expressed in the BL21(DE3) strain of
E. coli with a hexameric histidine at its N-terminal end.
The enzyme was isolated in the supernatant after lysis of the cells and
fractionated by ultracentrifugation. Western blotting using
anti-histidine antibody showed the presence of a band that migrated at
about 47.5 kDa on both reducing and nonreducing SDS-polyacrylamide gel
electrophoresis, indicating a monomeric enzyme. Among the carbohydrate
acceptors tested, N-acetylneuraminic acid and the
gangliosides GD3 and GQ1b were preferred
substrates. The cell-free enzyme reaction products obtained were
characterized by NMR and mass spectrometry, which indicated the
presence of both
2,9- and
2,8-linked polysialyl structure. The
K92 neuS gene was used to transform the K1 strain of
E. coli, the capsule of which contains only -8-NeuAc
2-
linkages. Analysis of the polysaccharides isolated from these
transformed cells is consistent with the presence of both -8-NeuAc
2-
and -9-NeuAc
2- linkages. Our results suggest that the
neuS gene product of E. coli K92 catalyzes the
synthesis of polysialic acid with
2,9- and
2,8-linkages in
vitro and in vivo.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
2,8-,
2,9-, or
2,8/
2,9-ketosidic linkages (2). The degree of
polymerization can extend beyond 200 sialic acid residues (3), thereby
constituting a structurally unique group of carbohydrate polymers which
covalently modify cell-surface glycoconjugates (4). Polysialylation of the mammalian neural cell adhesion molecules, for example, affects the
cell-cell adhesive interactions during embryogenesis, including neurite
fasciculation and neuromuscular interactions (5, 6). While the
neuroinvasive bacteria Escherichia coli K1 contain a homopolymer of -8-NeuAc
2- (7), the Neisseria meningitidis Group C (8, 9) displays a homopolymer of -9-NeuAc
2- linkages. On the
other hand, the polysialic acid capsular antigens of neuroinvasive E. coli K92 are composed of poly(-8NeuAc
2,9NeuAc
2-)
residues (10). Alternating linkages of
2,8NeuAc- and
2,9NeuAc-
could not be found in mammalian systems, and therefore could be
utilized to elicit immunological response. In fact, the heteropolymer
from K92 strain of E. coli is being imployed as a
carbohydrate vaccine in the clinical trial of patients suffering from
acute meningitidis (11).
2,8-sialosyl sialyltransferase, termed neuS, has been cloned. This gene was found to be
clustered in the kps region which is implicated in the
initiation, polymerization, and possibly translocation of polysialic
acid chains across the inner membrane (13, 19, 20). A similar gene has
been identified by hybridization to the K92 strain of E. coli, the capsule of which contains poly(-8NeuAc
2,9NeuAc
2-)
(10). The complete nucleotide sequence of this K92 neuS gene
showed that this gene product differs by 70 amino acids from the K1
neuS gene product (14). Although an in vitro
study indicated that the neuS from E. coli K1
coding for a 47-kDa protein has polysialyltransferase activity, no such
activity has yet been clearly demonstrated for the neuS
product from E. coli K92. In this study, we have cloned the
neuS gene from the K92 strain of E. coli by
PCR using the primers described previously (14), expressed
the gene in E. coli, and shown that the enzyme from this
gene catalyzes the synthesis of polysialic acids with both
2,8- and
2,9-linkages in vitro and in vivo.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
strain of
E. coli lacking the kps gene cluster does not
have sialyltransferase activity (18), it was used initially to express
the gene. This strain has a pilli forming gene in its chromosome and
therefore does not require any pressure for the expression of its sex
pilli. M13 phage containing the T7 RNA polymerase gene (Invitrogen) was
used to infect DH5
F' transformed with pRSET vector containing the
cloned neuS gene. The transformed cells were grown in LB
medium (with 1 mM MgCl2) containing 100 µg of
carbicillin/ml at 37 °C to A600 ~0.3 and then 1 mM IPTG was added. After 1 h of incubation, the M13/T7 phage was added to infect the cells as described by the supplier (Invitrogen), and harvested after 5 h of incubation. An enzyme activity assay and SDS-PAGE of the cell lysate (15 K supernatant) showed expression of the neuS gene in DH5
F'. A band
migrating as ~47.5 kDa in the 12% SDS-PAGE appeared within 1 h
of incubation after infection with the T7 RNA polymerase gene
containing M13 in the presence of IPTG (as judged by Western blot). The
relative intensity of the 47.5-kDa band increased with time and reached maximum after 4 h. Enzymatic assay of the cell-free extract using sialic acid as acceptor also indicated the expression of the K92 polysialyltransferase. However, the DH5
F' cells transformed with pRSET vector also yielded a band comigrating with the 47.5-kDa band in
SDS-PAGE. Attempts to separate these bands using
Ni2+-NTA-agarose proved to be difficult. We therefore
decided to express this protein in the HMS174(DE3)Lys or BL21(DE3)
strain of E. coli (Invitrogen).
-mercaptoethanol. Electrophoresis was performed using 10%
SDS-polyacrylamide gel in Tris/glycine SDS buffer. After the proteins
were transferred to a nitrocellulose membrane, the blot was blocked
with a blocking buffer (blotto in TBS and 0.1% Tween 20) and developed
by adsorption with the mouse anti-(His)5 monoclonal
antibody (Qiagen, Valencia, CA) diluted (1:500) with the blocking
buffer. The blot was incubated with horseradish peroxidase-conjugated
sheep anti-mouse secondary antibody (1:1000; Amersham Pharmacia
Biotech). The protein bands were visualized either by chemiluminescence
as suggested by the supplier of the reagents (Amersham Pharmacia
Biotech) or by staining with the immunoPure Metal Enhanced DAB
Substrate Kit (Pierce, Rockford, IL).
20 °C) absolute ethanol. The ethanol precipitation from 0.9 M CaCl2 was repeated three times. The final product was dialyzed against water and lyophilized. The final purification was done using a column (2 × 25 cm) of Bio-Gel P-2 (Amersham Pharmacia Biotech) eluted with water following the usual procedure, and verified by polyacrylamide gel electrophoresis following
the method of Troy and McCloskey (7). After hydrolysis by sulfuric acid
(0.1 N H2SO4, 80 °C),
quantitation of sialic acid was determined by the thiobarbituric acid
procedure as described previously (27).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
2,8-polysialyltransferase activity. Using the K1 neuS gene as a probe, Vimr et al.
(14) cloned a 1230-base pair gene (14) from the K92 strain of E. coli that had 87.3% homology to the K1 gene. The deduced protein
sequence from this gene indicated the same number of amino acids (total 409 amino acids) with 83% homology to that of K1 at the protein level.
Previous structural studies on the polysaccharide antigen of this
E. coli K92 strain (Bos-12) suggested the presence of polysialic acid with alternating
2,8- and
2,9-linkages (10). Therefore, the gene product from the K92 strain is assumed to confer
polysialyltransferase activity (14, 23). However, expression of the
neuS gene from K92 was not clearly demonstrated, nor was it
shown to form a polymer of sialic acid in vitro with
alternating
2,8/2,9-linkages.

View larger version (32K):
[in a new window]
Fig. 1.
Construction of the expression vector for the
K92 neuS expression as a fusion protein. The PCR fragment, 91.2 kilobases, obtained for the full-length form of the K92 neuS
gene using its genomic DNA as template, was subcloned in pRSET vector
(Novagen, Madison, WI) using two unique restriction sites,
BamHI and EcoRI. This resulted in the expression
of the protein with a hexameric histidine tag fused at its N-terminal
end. The vector provides the start codon followed by the sequence for
the hexameric histidine. The full-length form of the protein remains
mostly as membrane bound form. However, about 30-40% of the protein
is "released" in the 40 K Sup upon treatment with a detergent. This
released protein retains full catalytic activity and was used in this
study.
2,8/2,9-polysialyltransferase was also found to be present in the 40,000 supernatant. Our initial attempt to purify the protein using Ni2+-NTA-agarose column
failed. Although the fusion protein apparently binds to the
Ni2+-NTA-agarose, nonspecific binding with other cellular
proteins was also observed. Therefore, the 40 K Sup was used in this
study for enzyme assay and analysis of its product(s).

View larger version (44K):
[in a new window]
Fig. 2.
Western blot analysis of the K92 neuS
expressed protein. E. coli cells of BL21(DE3)
transformed with K92 neuS gene in the expression vector
pRSET were induced with IPTG (1 mM final concentration) and
harvested after 4 h. Cells transformed with pRSET vector only were
also grown and used as negative control. As a positive control,
BL21(DE3) previously transformed with the histidine-tagged thioesterase
gene subcloned in pET20B(+) were grown, induced, and harvested
similarly. After harvesting, the cells were lysed and the supernatants
were collected after centrifugation at 15,000 rpm (15 K Sup). The
proteins were run using a 12% SDS-PAGE as mentioned under "Materials
and Methods." The samples were: 15 K Sup from the negative control
(lane 1), 15 K Sup from the cells transformed with K92
neuS gene (lane 2), and 15 K Sup from the
positive control (lane 3). The blot was developed using
anti-(His)5 antibody (Qiagen) and metal enhanced DAB
substrate kit (Pierce). The neuS expressed
2,8/2,9-polysialyltransferase migrated in the gel at about 47.5 kDa.
In lane 3, the positive control for the Western blot showed
a band at ~23 kDa for the thioesterase. It may be noted that the
expression level for the neuS gene was comparatively lower
than the thioesterase gene.
2,8-linkages were not accepted,
whereas the corresponding dimer and trimer (Calbiochem) served as poor
acceptors. Among the glycolipids tested, GD3 and
GQ1b also served as good acceptors. However, other
sialylgangliosides tested were poor substrates (Table I).

View larger version (37K):
[in a new window]
Fig. 3.
Analysis of the enzyme reaction products by
thin-layer chromatography (TLC). The 40 K Sup was used as a source
of the enzyme in the reaction mixture containing 1 mM
acceptor and CMP-[14C]NeuAc (9 nmol; 1 µCi) as donor in
a reaction buffer containing 25 mM Tris-HCl (pH 8.0), 5 mM MgCl2, 5 mM DTT, and 0.5%
Triton CF-54. As an example, analysis was shown with the reaction
mixture containing sialic acid and GM3 as acceptors and
CMP-[14C]NeuAc as donor substrate. As a negative control,
the reaction mixture contained sialic acid as acceptor without the
addition of any enzyme. For A and B, Silica Gel
60 TLC plates were used for the samples: reaction mixture without the
enzyme (lane 1), GM3 as acceptor (lane
2), sialic acid as acceptor (lane 3), and reaction
mixture without exogenous sialic acid (lane 4). The solvents
used were: (a) 1-propanol, 1 M NH4OH, water;
7:1:2; (b) chloroform, methanol, 0.02% CaCl2; 45:55:10.
The reaction mixtures were also analyzed by DEAE-cellulose TLC. After
the reaction was complete, a part of the sample was acidified with 10%
acetic acid and incubated for 30 min at room temperature. For
C, DEAE-cellulose TLC plate was used. The samples were:
reaction mixture with sialic acid as acceptor (lane 1) and
after acidification (lane 2); reaction mixture without
enzyme (lane 3) and after acidification (lane 4);
using GM3 as acceptor (lane 5) and after
acidification (lane 6); reaction mixture without exogenous
acceptor (lane 7) and after acidification (lane
8). The solvents in C used were: 1-propanol, 14.5 M NH4OH, water; 6:1:3. The plates were dried
after the run and exposed to Kodak XAR-5 film. The arrow
indicates the position of the potential cell-free reaction product(s).
The position of CMP-NeuAc and free sialic acid were also shown. We
found that both the enzyme and its reaction products are unstable and
degrade over time.
Substrate specificity of the neuS gene product of E. coli K92 expressed
in BL21(DE3)
70 °C. The area corresponding to the reaction product was marked,
cut and then counted in scintillation fluid.
H+)
and at
m/z 1401 for (M-4 H2O
H). This spectrum
was similar to that of the commercially obtained
2,8-polysialic acid
(pentamer; Calbiochem). While the authentic sample showed a
fragmentation pattern accounting for the tetramer (m/z at
1182 for M-3H2O
H+)
, trimer
(m/z at 890 for
M-3H2O
H+)
, dimer (m/z
at 599 for M-3H2O
H+)
, and monomer
(m/z at 308 for
M-3H2O
H+)
fragments (see Fig.
4A), the fragmentation pattern for the reaction product was
slightly different, probably due to the presence of alternating
2,8-
and
2,9-linkages in the cell-free reaction product(s). The degree of
polymerization appears to be limited by the concentration of CMP-NeuAc.
The production of a pentamer as the major product in the cell-free
reaction is probably due to the limitation of CMP-NeuAc concentration
along with the limited degree of polymerization. Increasing the amount
of CMP-NeuAc in the cell-free reaction indeed increases the chain
length of the sialyl polymer as judged by mass spectrometry (Fig.
5). While the MALDI-MS (Core Facility,
The Scripps Research Institute) of the commercially available pentamer
(Calbiochem) showed a peak for m/z at 1473, a peak at
m/z 1474 was obtained with 10 mM CMP-NeuAc and
at m/z 3830 with 20-30 mM
CMP-NeuAc.

View larger version (27K):
[in a new window]
Fig. 4.
Mass-spectral analysis of the enzyme reaction
product. For the mass spectral analysis, the cell-free reaction
was carried out using 40 K Sup. The reaction mixture contained 1 mM sialic acid and 10 mM CMP-NeuAc as donor in
a reaction buffer containing 25 mM Tris-HCl (pH 8.0), 5 mM MgCl2, 5 mM DTT, 0.5% Triton
CF-54. To drive the forward reaction, the liberated CMP was removed by
the addition of alkaline phosphatase (1 units). After the reaction was
over, the reaction material was passed through an Amicon filter (10 MWCO) and the filtrate was used for analysis. The cell-free enzyme
reaction product behaved similar to the pentameric sialic acid
(Calbiochem), on TLC. in various solvent systems. Mass spectra were
compared with that of commercially available pentameric sialic acid.
Negative ion mass spectrum (ES-MS) of: A, standard
pentameric polysialic acid; and B, cell-free reaction
product. The major peaks for m/z were marked by an
arrow and described in the text. The molecular ion (M
H+)
was also shown. Some minor products
with higher mass (m/z) were also observed.

View larger version (13K):
[in a new window]
Fig. 5.
Mass spectral analysis of the enzyme reaction
products with increasing concentration of CMP-NeuAc. The cell-free
enzyme reactions were performed as described in the legend to Fig. 4
with 1 mM sialic acid and increasing concentration of
CMP-NeuAc (10, 15, 20, and 30 mM). After the reaction was
complete, the materials were filtered (Amicon; 10 MWCO) and the
filtrate from each reaction tube was directly used for
mass-spectrometry (MALDI-MS). The spectra were: A, standard
pentamer (Calbiochem); B, reaction product using 10 mM CMP-NeuAc; and C, reaction product using 20 mM CMP-NeuAc. The major peaks for m/z were shown
by the arrow and described in the text. A similar spectrum
(as C) was observed using 30 mM CMP-NeuAc.
2,8-linked sialic acids in its capsule was transformed with the
neuS gene from K92. This was done to investigate whether the
K92 neuS gene product competes with the endogenous
2,8-polysialyltransferase for the same endogenous acceptor in
vivo. The capsular polysaccharide from the transformed K1 was
isolated and purified by Bio-Gel P-2 column chromatography as mentioned
under "Materials and Methods." 13C NMR of this
polysaccharide in D2O showed a spectrum different from that
of the K1- and K92-derived polysialic acids (Fig.
6). The major peaks for the
NCOCH3 and NCOCH3 were
similar to those of both K1 and K92. However, the signal for C-2 at
103.44 was comparatively weaker. This may be due to the complex
nature of the polysaccharide from transformed cells. Moreover, the
13C NMR spectra obtained for the transformed K1 was similar
to that of the polymer obtained from the K92 strain of E. coli, which also showed two closely adjacent signals at
23.36 and 23.51. It was shown earlier that this particular strain of E. coli contains heteropolysialyl oligosaccharide with alternating
2,8/2,9-linkages (10). This complexity was also evident in the
1H NMR spectrum (Fig. 7)
which showed two peaks at
1.99 and
1.96. While a detailed
structural study is in progress, the preliminary data indicates that
the polysaccharide isolated from the transformed K1 has both
2,8-
and
2,9-linkages present in random sequences. This suggests that not
only is the K92 neuS gene functional in the K1 strain of
E. coli, but also that its expression disrupted normal
polysialyl chain elongation. This result is probably due to the
competition for the same endogenous acceptor in vivo. It also suggests that the endogenous acceptor is neither sialic acid nor
colominic acid, but is common for both the
2,8- and
2,8/2,9-polysialyltransferases.

View larger version (31K):
[in a new window]
Fig. 6.
13C NMR analysis of the capsular
polysaccharide. The spectra were recorded on a Brucker DRX-600
spectrometer. The scale is in parts per million and relative to
external dimethyl sulfoxide. The spectra of the purified capsular
polysaccharies were from K1 (A), K1 transformed with
K92neuS (B), and K92 (C). The
numbering of the carbon atoms is based on the previously published
results (10).

View larger version (13K):
[in a new window]
Fig. 7.
1H NMR analysis of the capsular
polysaccharide of K1 transformed with K92/neuS. The
spectra were recorded on a Brucker DRX-600 at an ambient temperature.
Only the region for amide methyl groups from
2,8- and
2,9-linkages of the purified capsular polysaccharide have been shown
for comparison. The isolation and purification of the capsular
polysaccharides were described under "Materials and Methods." The
spectra of the capsular polysaccharides were from K1 (A),
K92 (B), and K1 transformed with K92/neuS (C).
While the K1 sample showed only a singlet at
1.99, K92 showed two
peaks at
2.00 and
1.96. The spectrum obtained from the
transformed K1 was broad and complex, especially at ~
1.99.
2,8-linked oligomeric
sialic acid (33, 34), the carboxyl group of the nonreducing end sialic acid may exist as an open form (Fig.
9).

View larger version (31K):
[in a new window]
Fig. 8.
13C NMR analysis of the enzyme
reaction product. After the enzyme reaction, the protein was
removed by filtration (Amicon; 10,000). The enzyme reaction product was
separated from unreacted sialic acid and CMP-NeuAc by passing through a
column of Dowex 1X8 (PO4
form) eluting
with phosphate buffer. The product was collected in the void volume and
desalted by passing through a small column of Sephadex G-50 eluting
with water. The desired material was collected in the void volume,
freeze-dried, and dissolved in D2O for NMR analysis. The
spectra were recorded on a Brucker DRX-600 spectrometer at an ambient
temperature (20 °C). The scale is in parts per million and relative
to external dimethyl sulfoxide. Spectrum A, commercially
available
2,8-linked pentameric sialic acid used as standard,
results from approximately 25,000 accumulations. Spectrum B,
partially purified cell-free reaction product, results from
approximately 40,000 accumulations.

View larger version (20K):
[in a new window]
Fig. 9.
Proposed structure of the cell-free reaction
product. The product obtained by the cell-free reaction using K92
neuS protein, indicated the structure of a pentameric sialic
acid with alternating
2,9/2,8-linkages (I). The proposed
major lactone form (II) obtained in the enzymatic reaction
is also shown.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
2, 9NeuAc
2-) (10). This gene product differs by 70 amino acids when
compared with that of the neuS gene product of the K1 strain (14). Of the observed amino acid replacements, 36 were conservative. On
the basis of such homology, it was postulated that the K92 gene evolved
from neuS of K1 (14). By complementation assay, the K92
neuS gene was shown by this group (23) to express
polysialyltransferase activity yielding a product that was recognized
by meningitidis C antiserum in vivo, suggesting that this
gene might produce sialoside with alternating
2,8/2,9-polysialyl
linkages. However, because meningitidis C antiserum interacts with both
homopolysialic acid (-9-NeuAc
2-) from N. meningitidis
Group C and heteropolysialic acid (-8Neu Ac
2,9NeuAc
2-) from
the K92 strain of E. coli (38), structural identification of
the cell-free reaction product(s) was warranted. Previously, the
expression of the K92 neuS gene was not clearly
demonstrated, nor was it shown that this gene product catalyzes the
synthesis of heteropolysialic acid (-8NeuAc
2,9NeuAc
2-) in
vitro.
2,8/2,9-polysialyltransferase activity both in vitro and
in vivo. Apparently a single polypeptide (as judged by the
Western blot) for this polysialyltransferase catalyzes the synthesis of
polysialic acid with alternating
2,9- and
2,8-linkages.
Previously, bacterial KDO-transferase was shown to possess such dual
linkage specificity (40). Thus, enzymes capable of forming multiple
different linkages may not be uncommon in nature. A recent report on
the study of a crude preparation of polysialyltransferase from K92
indicates that the enzyme recognizes an
2,8-glycosidic linkage of
sialic acid at the nonreducing end (41), consistent with our finding.
It also indicates that the
2,9-linked homopolysialic acid or the
2,8/
2,9-linked heteropolymer of sialic acid with
2,9-linkage
at the nonreducing end is not acceptable (41), and the enzyme may
catalyze the sequential transfer of a preformed
2,8-linked dimer to
the 9-position of the acceptor, a novel mechanism which remains to be
proven. Work is in progress to purify the enzyme and to define the
substrate specificity and mechanism.
| |
FOOTNOTES |
|---|
* The work was supported in part by the National Institutes of Health Grant GM44154 (to C. H. W.). This paper was presented at the 19th International Carbohydrate Symposium, August 9, 1998, San Diego.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Contributed equally to this work.
§ To whom correspondence should be addressed: Dept. of Chemistry, BCC 338, The Scripps Research Institute, 10550 N. Torrey Pines Rd., San Diego, CA 92037. Tel: 858-784-2487; Fax: 858-784-2409; E-mail: wong@scripps.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
NeuAc, neuraminic
acid;
PCR, polymerase chain reaction;
CMP-NeuAc, CMP-neuraminic acid or
CMP-sialic acid;
IPTG, isopropyl-1-thio-
-D-galactopyranoside;
PAGE, polyacrylamide gel electrophoresis;
DTT, dithiothreitol;
ES-MS, electrospray mass spectrometry;
GM3, NeuAc
2,3Gal
1,4Glc
-ceramide;
GD3, NeuAc
2,8NeuAc
2,3Gal
1,4Gal
-ceramide;
GQ1b, NueAc
2,8
NeuAc
2,3Gal
1,3GalNAc
1,4(NueAc
2,8Neu
2,3)Gal
1,4Glc
-ceramide;
GD2, GalNAc
1,4(NeuAc
2,8NeuAc
2,3)Gal
1,4Glc
-ceramide;
GT1a, NueAc
2,3Gal
1,3(NeuAc
2,6)GalNAc
1,4(Neu
Ac
2,3)Gal
1,4Glc
-ceramide;
GT1b, NeuAc
2,3Gal
1,3GalNAc
1,4 (NeuAc
2,8
NeuAc
2,3)Gal
1,4Glc
-ceramide.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Schauer, R., Kelm, S., Reuter, G., Roggentin, P., and Shaw, L. (1995) in Biology of the Sialic Acids (Rosenberg, A., ed) , pp. 7-67, Plenum Press, New York |
| 2. |
Troy, F. A.
(1992)
Glycobiology
2,
5-23 |
| 3. |
Rohr, T. E.,
and Troy, F. A.
(1980)
J. Biol. Chem.
255,
2332-2342 |
| 4. | Troy, F. A. (1990) Trends Glycosci. Glycotechnol. 2, 430-449 |
| 5. | Edelman, G. M. (1985) Cold Spring Harbor Symp. Quant. Biol. 50, 877-889[Medline] [Order article via Infotrieve] |
| 6. |
Cunningham, B. A.,
Hemperly, J. J.,
Murray, B. A.,
Prediger, E. A.,
Brackenbury, R.,
and Edelman, G. M.
(1987)
Science
236,
799-806 |
| 7. |
Troy, F. A.,
and McCloskey, M. A.
(1979)
J. Biol. Chem.
254,
7377-7387 |
| 8. |
Liu, T.-Y.,
Gotschlich, E. C.,
Donne, F. T.,
and Jonssen, E. K.
(1971)
J. Biol. Chem.
246,
4703-4712 |
| 9. |
Vann, W. F.,
Liu, T.-Y.,
and Robbins, J. B.
(1978)
J. Bacteriol.
133,
1300-1306 |
| 10. | Egan, W., Liu, T.-Y., Dorow, D., Cohen, J. S., Robbins, J. D., Gotschlich, E. C., and Robbins, J. B. (1977) Biochemistry 16, 3687-3692[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Devi, S. J.,
Robbins, J. B.,
and Schneerson, R.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
7175-7179 |
| 12. | Tsuji, S., Datta, A. K., and Paulson, J. C. (1996) Glycobiology 6, v-vii |
| 13. |
Weisgerber, C.,
Hansen, A.,
and Frosch, M.
(1991)
Glycobiology
1,
357-365 |
| 14. |
Vimr, E. R.,
Bergstrom, R.,
Steenbergen, S. M.,
Boulnois, G.,
and Roberts, I.
(1992)
J. Bacteriol
174,
5127-5131 |
| 15. | Gilbert, M., Cunningham, A.-M., Watson, D. C., Martin, A., Richards, J. C., and Wakarchuk, W. W. (1997) Eur. J. Biochem. 249, 187-194[Medline] [Order article via Infotrieve] |
| 16. |
Yamamoto, T.,
Nakashizuka, M.,
and Terada, I.
(1998)
J. Biochem. (Tokyo)
123,
94-100 |
| 17. |
Kundig, F. D.,
Aminoff, D.,
and Roseman, S.
(1971)
J. Biol. Chem.
246,
2543-2550 |
| 18. | Steenbergen, S. M., and Vimr, E. R. (1990) Mol. Microbiol. 4, 603-611[Medline] [Order article via Infotrieve] |
| 19. |
Weisgerber, C.,
and Troy, F. A.
(1990)
J. Biol. Chem.
265,
1578-1587 |
| 20. | Steenbergen, S. M., and Vimr, E. R. (1991) Glycoconjug. J. 8, 145 |
| 21. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 22. | Harlow, E., and Lane, D. (1988) Antibodies , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 23. |
Steenbergen, S. M.,
Wrona, T. J.,
and Vimr, E. R.
(1992)
J. Bacteriol.
174,
1099-1108 |
| 24. | Williams, M. A., Kitagawa, H., Datta, A. K., Paulson, J. C., and Jamieson, J. C. (1995) Glycoconj. J. 12, 755-761[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Corfield, A. P., and Schauer, R. (1982) Cell Biol. Monogr. 10, 77-94 |
| 26. |
Kasper, D. L.,
Winkelhake, J. L.,
Zollinger, W. D.,
Brandt, B.,
and Artenstein, M. S.
(1973)
J. Immunol.
110,
262-268 |
| 27. | Liu, J. L-C., Shen, G-J., Ichikawa, Y., Rutan, J. F., Zapata, G., Vann, W. F., and Wong, C-H. (1992) J. Am. Chem. Soc. 114, 3901-3910[CrossRef] |
| 28. |
Hopp, T. P.,
and Woods, K. R.
(1981)
Proc. Natl. Acad. Sci. U. S. A.
78,
3824-3828 |
| 29. | Kyte, J., and Doolittle, R. F. (1982) J. Mol. Biol. 157, 105-132[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
Datta, A. K.,
Sinha, A.,
and Paulson, J. C.
(1998)
J. Biol. Chem.
273,
9608-9614 |
| 31. | Vanhoop, G., Goossens, F., De Meester, I., Hendricks, D., and Scharpe, S. (1995) FASEB J. 9, 736-744[Abstract] |
| 32. |
Weinstein, J.,
Lee, E. U.,
McEntee, K.,
Lai, P.-H.,
and Paulson, J. C.
(1987)
J. Biol. Chem.
262,
17735-17743 |
| 33. | Cheng, M.-C., Lin, C.-H., Khoo, K.-H., and Wu, S.-H. (1999) Angew. Chem. Int. Ed. Engl. 38, 686-689[CrossRef] |
| 34. |
Zhang, Y.,
and Lee, Y. C.
(1999)
J. Biol. Chem.
274,
6183-6189 |
| 35. | Barry, G. T. (1965) Bull. Soc. Chim. Biol. 47, 529-533.34 |
| 36. | Barry, G. T., Abbot, V., and Tsai, T. (1962) J. Gen. Microbiol. 29, 335-352 |
| 37. | Glode, M. P., Robbins, J. B., Liu, T-Y., Gotschlich, E. C., Orskov, I., and Orskov, F. (1977) J. Infect. Dis. 135, 94-102[Medline] [Order article via Infotrieve] |
| 38. | Pelkonen, S. (1990) Curr. Microbiol. 21, 23-28 |
| 39. |
Clementz, T.,
and Raetz, C. R. H.
(1991)
J. Biol. Chem.
266,
9687-9696 |
| 40. | Lee, Y-L., Chen, J. C., and Shaw, J-F. (1997) Biochem. Biophys. Res. Commun. 231, 452-456[CrossRef][Medline] [Order article via Infotrieve] |
| 41. |
Chao, C.-F.,
Chuang, H.-C.,
Chiou, S.-T.,
and Liu, T.-Y
(1999)
J. Biol. Chem.
274,
18206-18212 |
This article has been cited by other articles:
![]() |
L. M Willis, M. Gilbert, M.-F. Karwaski, M.-C. Blanchard, and W. W Wakarchuk Characterization of the {alpha}-2,8-polysialyltransferase from Neisseria meningitidis with synthetic acceptors, and the development of a self-priming polysialyltransferase fusion enzyme Glycobiology, February 1, 2008; 18(2): 177 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsukamoto, Y. Takakura, T. Mine, and T. Yamamoto Photobacterium sp. JT-ISH-224 Produces Two Sialyltransferases, {alpha}-/{beta}-Galactoside {alpha}2,3-Sialyltransferase and {beta}-Galactoside {alpha}2,6-Sialyltransferase J. Biochem., February 1, 2008; 143(2): 187 - 197. [Abstract] [Full Text] [PDF] |
||||